Tratamento
Wondering whether to wait or act on Ozempic loose skin after weight loss? This guide covers timing, which specialist to see first, and what each option can and cannot do.
Already looking into a thigh lift after weight loss? Here's what to bring, what your surgeon will measure, and what to ask before the first visit.
Why a registered Wegovy pen may still not reach the SUS pharmacy, and how Conitec's technical process decides what the public system can offer.
Anvisa has approved five new GLP-1 pens. Here is how to read the notice, verify a pen yourself, and separate approval from pharmacy stock, price and coverage.
Retatrutide is an experimental triple agonist that keeps showing up in studies alongside semaglutide. Here is what it is, what the data show so far, and what remains open.
Thinking about moving from the Wegovy pen to the Wegovy pill? Here's what to confirm with your prescriber, from dosing and daily timing to side effects and insurance paperwork.
Ozempic, Wegovy and semaglutide are not the same label. Here's what the approvals cover, what off-label prescribing means for a teen, and what parents should watch for.
Thinking about Ozempic for kidney disease? Here is what your doctor checks, from creatinine and albumin results to heart, eye, and medication history.
Ozempic SUS coverage depends on protocols, indications, and paperwork. Here is how the decision works, what to do after a denial, and how to keep treatment going.
The indication printed on your Ozempic prescription can change how your health plan reviews your request. Here is how to read it and what to check.
